Arthur D. LittleArthur D. Little

Publications / Reports

Healthcare Innovation

Healthcare Innovation

Value Creation in a Patient-Centric Healthcare Ecosystem

The rapid growth of specialty pharmaceuticals is creating structural changes across the entire healthcare landscape. Substantial differences between specialty and traditional pharmaceuticals not only structurally and chemically but often in terms of distribution, marketing, and regulation are creating new market opportunities while simultaneously challenging the current healthcare ecosystem.

The discovery, development, manufacturing, delivery, and sales of specialty pharmaceuticals require new and advanced tools, technologies, and expertise.

While these structural changes present significant challenges to traditional pharmaceutical manufacturers to comply with new health regulations, they also present opportunities for a variety of stakeholders from biotechnology and diagnostics companies to new entrants, such as third party logistic providers, packaging manufacturers, health economics, information technology, and telecommunications firms.

Released: June 2014

Download File ADL_Healthcare_Innovation.pdf (.PDF, 907 Kb)

previous report | next report

back